Dupilumab Improves Lung Function in Asthma and ABPA



Dupilumab improves lung function and reduces corticosteroid dependence in patients with asthma and allergic bronchopulmonary aspergillosis compared with placebo, a phase 2 trial finds.
Medscape Medical News



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *